The development of biological drugs such as gene and cell therapies and vaccines is boosting the production of injectable drug products in the global healthcare market. Chronic illnesses, ageing population, and faster approval of sterile injectables compared to other drug types are some of the factors responsible for the increase in demand for pharmaceutical injectables.

Pharmaceutical companies are turning to injectables pharmaceutical companies in contract manufacturing to meet this growing demand. Generic injectables companies are also growing significantly due to the extensive use of generic injectables in the treatment of a wide range of chronic diseases while providing the same efficacy and safety as the reference injectables.

Discover the top commercial dose pharmaceutical injectables companies in contract manufacturing

Pharmaceutical Technology has listed the leading contract manufacturers of commercial dose injectables, based on its intel, insights, and decades of experience in the sector.

The list includes providers of various services and solutions including, but not limited to:

  • Hypodermal injection needles
  • Cartridge-based injections
  • Solubiliser and emulsifier agents
  • Type II premium injection vials, and ampoules
  • Implanters
  • Dry injections

The information contained within the download document is intended for process development managers, production assistants, injectable device development managers, validation officers and any other individual involved in drug injectables manufacturing.

The document contains detailed information on the suppliers and their product offerings, alongside contact details to aid your purchasing or hiring decision.

Related Buyer’s Guides which cover an extensive range of pharmaceutical equipment manufacturers, service providers and technology, can also be found here.

Factors driving the demand for injectables

Rapid absorption, faster drug action, lower risk of drug degradation by gastric secretion, and less concentration of the drug are driving the demand for injectable commercial doses. Injectables pharmaceutical companies are gaining traction for providing manufacturing support for monoclonal antibody therapies, large molecule injectable drugs, and drugs treating infectious diseases.

Factors such as the growing prevalence of chronic diseases, shorter and cheaper research and development (R&D) cycles of generic injectables, and growing focus on the treatment of rare diseases are boosting the growth of generic injectables companies in the global market.

Delivery innovations by injectables pharmaceutical companies

Injectables pharmaceutical companies are focusing on improving user convenience and patient friendliness of injectable drugs by using innovative packaging and delivery systems. Prefilled syringes that are user-friendly and enable patients to self-administer the drug from the comfort of their homes are becoming increasingly popular.

Pens, autoinjectors and infusion pumps are other packaging forms for injectable drugs that are easy to handle and facilitate long-term administration. Furthermore, connected autoinjectors and infusion pumps are emerging that feature data capture and reporting capabilities.

Wearable forms of injectable drugs such as clip-on and stick-on parenteral delivery systems are also convenient and can fit discreetly into clothing.